retatrutide phase 2 nejm 2023 obesity trial jastreboff 💉 may be redefining treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic 📋FAT LOSS WITH Retatrutide.. .

For Dr Sinclair, the unknowns of the knock-off retatrutide are the primary concern

The table rates its evidence level as high with randomized controlled trial data available, versus moderate for B12 supplementation and low-to-moderate for choline and inositol

Do not exceed the expressly recommended daily dose

Are compounded GLP-1 medications the same as FDA-approved versions

For patients seeking deeper personalization, PlexusDx offers the Precision Peptide Genetic Test ($298), which maps 14 pathways across 49 peptides to reveal your individual response predispositions

I had been with another company before, but constant shipping delays and poor communication left me frustrated